| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.
|
N Engl J Med
|
2003
|
7.74
|
|
2
|
A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study.
|
Lancet
|
2011
|
5.61
|
|
3
|
Retracted
Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial.
|
JAMA
|
2013
|
4.88
|
|
4
|
2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial.
|
J Am Coll Cardiol
|
2012
|
3.15
|
|
5
|
Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome.
|
J Am Coll Cardiol
|
2013
|
2.28
|
|
6
|
'Reverse white-coat hypertension' in older hypertensives.
|
J Hypertens
|
2002
|
2.17
|
|
7
|
Rate of morning increase in blood pressure is elevated in hypertensives.
|
Am J Hypertens
|
2006
|
2.15
|
|
8
|
Diabetes detection in Australian general practice: a comparison of diagnostic criteria.
|
Med J Aust
|
2002
|
2.14
|
|
9
|
Similar effects of treatment on central and brachial blood pressures in older hypertensive subjects in the Second Australian National Blood Pressure Trial.
|
Hypertension
|
2007
|
2.13
|
|
10
|
Brachial blood pressure but not carotid arterial waveforms predict cardiovascular events in elderly female hypertensives.
|
Hypertension
|
2006
|
1.90
|
|
11
|
Retracted
Brief communication: ramipril markedly improves walking ability in patients with peripheral arterial disease: a randomized trial.
|
Ann Intern Med
|
2006
|
1.71
|
|
12
|
Contemporary results show repeat coronary artery bypass grafting remains a risk factor for operative mortality.
|
Ann Thorac Surg
|
2009
|
1.69
|
|
13
|
Does prior percutaneous coronary intervention adversely affect early and mid-term survival after coronary artery surgery?
|
JACC Cardiovasc Interv
|
2009
|
1.61
|
|
14
|
Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents.
|
Catheter Cardiovasc Interv
|
2009
|
1.51
|
|
15
|
Factors associated with deep sternal wound infection and haemorrhage following cardiac surgery in Victoria.
|
Interact Cardiovasc Thorac Surg
|
2006
|
1.48
|
|
16
|
Should aspirin be used for the primary prevention of cardiovascular disease in people with diabetes?
|
Med J Aust
|
2009
|
1.45
|
|
17
|
Progress towards a National Cardiac Procedure Database--development of the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and Melbourne Interventional Group (MIG) registries.
|
Heart Lung Circ
|
2010
|
1.44
|
|
18
|
Ten-year legacy effects of baseline blood pressure 'treatment naivety' in the Second Australian National Blood Pressure study.
|
J Hypertens
|
2015
|
1.41
|
|
19
|
Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes.
|
J Hypertens
|
2005
|
1.40
|
|
20
|
Amino-terminal-pro-B-type natriuretic peptide levels and low diastolic blood pressure: potential relevance to the diastolic J-curve.
|
J Hypertens
|
2014
|
1.39
|
|
21
|
Recent trends in Australian percutaneous coronary intervention practice: insights from the Melbourne Interventional Group registry.
|
Med J Aust
|
2011
|
1.38
|
|
22
|
Validated Assessment Tools and Maintenance of Certification in Plastic Surgery: Current Status, Challenges, and Future Possibilities.
|
Plast Reconstr Surg
|
2016
|
1.37
|
|
23
|
Comparing trends in BMI and waist circumference.
|
Obesity (Silver Spring)
|
2010
|
1.26
|
|
24
|
Trends in BMI of urban Australian adults, 1980-2000.
|
Public Health Nutr
|
2009
|
1.18
|
|
25
|
Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2).
|
Med J Aust
|
2006
|
1.16
|
|
26
|
Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry.
|
JACC Cardiovasc Interv
|
2010
|
1.14
|
|
27
|
Usefulness of postoperative atrial fibrillation as an independent predictor for worse early and late outcomes after isolated coronary artery bypass grafting (multicenter Australian study of 19,497 patients).
|
Am J Cardiol
|
2011
|
1.07
|
|
28
|
Smaller aortic dimensions do not fully account for the greater pulse pressure in elderly female hypertensives.
|
Hypertension
|
2008
|
1.05
|
|
29
|
Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis.
|
J Hypertens
|
2009
|
1.02
|
|
30
|
Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary intervention.
|
Am J Cardiol
|
2011
|
0.95
|
|
31
|
The heart of the matter: health status of aged care clients receiving home- and community-based care.
|
J Aging Res
|
2010
|
0.93
|
|
32
|
Sex differences in outcomes following isolated coronary artery bypass graft surgery in Australian patients: analysis of the Australasian Society of Cardiac and Thoracic Surgeons cardiac surgery database.
|
Eur J Cardiothorac Surg
|
2011
|
0.92
|
|
33
|
Validity of self-reported hypertension: findings from the Thai Cohort Study compared to physician telephone interview.
|
Glob J Health Sci
|
2013
|
0.92
|
|
34
|
Trends in coronary artery bypass graft surgery in Victoria, 2001-2006: findings from the Australasian Society of Cardiac and Thoracic Surgeons database project.
|
Med J Aust
|
2008
|
0.91
|
|
35
|
Ankle-Brachial Index determination and peripheral arterial disease diagnosis by an oscillometric blood pressure device in primary care: validation and diagnostic accuracy study.
|
BMJ Open
|
2012
|
0.90
|
|
36
|
Large artery stiffness is not related to plasma cholesterol in older subjects with hypertension.
|
Arterioscler Thromb Vasc Biol
|
2004
|
0.88
|
|
37
|
Critical analysis of early and late outcomes after isolated coronary artery bypass surgery in elderly patients.
|
Ann Thorac Surg
|
2011
|
0.88
|
|
38
|
Prevalence of underweight, overweight and obesity in urban Hanoi, Vietnam.
|
Asia Pac J Clin Nutr
|
2009
|
0.87
|
|
39
|
Health risk factors and the incidence of hypertension: 4-year prospective findings from a national cohort of 60 569 Thai Open University students.
|
BMJ Open
|
2013
|
0.87
|
|
40
|
Impact of prosthesis--patient mismatch after mitral valve replacement: a multicentre analysis of early outcomes and mid-term survival.
|
Heart
|
2011
|
0.86
|
|
41
|
The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: best case scenario analysis using a Markov model.
|
BMJ
|
2012
|
0.85
|
|
42
|
The role of traditional cardiovascular risk factors among patients with rheumatoid arthritis.
|
J Rheumatol
|
2009
|
0.85
|
|
43
|
Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study.
|
Med J Aust
|
2008
|
0.84
|
|
44
|
Health-risk factors and the prevalence of hypertension: cross-sectional findings from a national cohort of 87,143 Thai Open University students.
|
Glob J Health Sci
|
2013
|
0.84
|
|
45
|
Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromes.
|
Int J Cardiol
|
2010
|
0.84
|
|
46
|
Overview of pharmacoeconomic modelling methods.
|
Br J Clin Pharmacol
|
2013
|
0.84
|
|
47
|
Postoperative atrial fibrillation after isolated aortic valve replacement: a cause for concern?
|
Ann Thorac Surg
|
2012
|
0.83
|
|
48
|
Impact of left ventricular dysfunction on early and late outcomes in patients undergoing concomitant aortic valve replacement and coronary artery bypass graft surgery.
|
Cardiol J
|
2013
|
0.82
|
|
49
|
An Australian risk prediction model for determining early mortality following aortic valve replacement.
|
Eur J Cardiothorac Surg
|
2011
|
0.82
|
|
50
|
Funding linked to ongoing research: impact of the bosentan patient registry on pricing in Australia.
|
Value Health
|
2011
|
0.82
|
|
51
|
Systolic blood pressure variability is an important predictor of cardiovascular outcomes in elderly hypertensive patients.
|
J Hypertens
|
2014
|
0.82
|
|
52
|
Early and late outcomes after isolated aortic valve replacement in octogenarians: an Australasian Society of Cardiac and Thoracic Surgeons Cardiac Surgery Database Study.
|
Eur J Cardiothorac Surg
|
2012
|
0.81
|
|
53
|
Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms.
|
Eur J Prev Cardiol
|
2012
|
0.81
|
|
54
|
Smoking and primary total hip or knee replacement due to osteoarthritis in 54,288 elderly men and women.
|
BMC Musculoskelet Disord
|
2013
|
0.81
|
|
55
|
Outcomes after percutaneous coronary intervention in contemporary Australian practice: insights from a large multicentre registry.
|
Med J Aust
|
2008
|
0.81
|
|
56
|
The economic implications of treating atherothrombotic disease in Australia, from the government perspective.
|
Clin Ther
|
2010
|
0.81
|
|
57
|
Nonsymmetrical double logistic analysis of ambulatory blood pressure recordings.
|
J Appl Physiol (1985)
|
2004
|
0.81
|
|
58
|
Quality control activities associated with registries in interventional cardiology and surgery.
|
Heart Lung Circ
|
2011
|
0.80
|
|
59
|
Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries.
|
Heart Lung Circ
|
2009
|
0.80
|
|
60
|
N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: results of the SCReening Evaluationof the Evolution of New-Heart Failure Study (SCREEN-HF).
|
Eur J Heart Fail
|
2013
|
0.80
|
|
61
|
Does patient gender affect outcomes after concomitant coronary artery bypass graft and aortic valve replacement? An Australian Society of Cardiac and Thoracic Surgeons Database study.
|
Cardiology
|
2011
|
0.80
|
|
62
|
Cardiovascular disease in Australia: calm before a new storm?
|
Clin Exp Pharmacol Physiol
|
2013
|
0.80
|
|
63
|
Is it cost-effective to increase aspirin use in outpatient settings for primary or secondary prevention? Simulation data from the REACH Registry Australian Cohort.
|
Cardiovasc Ther
|
2011
|
0.80
|
|
64
|
Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry).
|
Am J Cardiol
|
2008
|
0.80
|
|
65
|
Prediction of cardiovascular events in subjects in the second Australian National Blood Pressure study.
|
Hypertension
|
2010
|
0.80
|
|
66
|
NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure study (SCREEN-HF).
|
Int J Cardiol
|
2013
|
0.79
|
|
67
|
Short- and long-term survival in treated elderly hypertensive patients with or without diabetes: findings from the Second Australian National Blood Pressure study.
|
Am J Hypertens
|
2013
|
0.79
|
|
68
|
A score for the prediction of cardiovascular events in the hypertensive aged.
|
Am J Hypertens
|
2011
|
0.79
|
|
69
|
Review on cardiovascular risk prediction.
|
Cardiovasc Ther
|
2015
|
0.78
|
|
70
|
A propensity-score matched analysis on the impact of postoperative atrial fibrillation on the early and late outcomes after concomitant aortic valve replacement and coronary artery bypass graft surgery.
|
J Cardiovasc Med (Hagerstown)
|
2014
|
0.78
|
|
71
|
Examining the signs and symptoms experienced by individuals with suspected acute coronary syndrome in the Asia-Pacific region: a prospective observational study.
|
Ann Emerg Med
|
2012
|
0.78
|
|
72
|
The impact of lost therapeutic benefit (LTB) in high-risk hypertensive patients: 2-year follow-up data from the Australian REACH registry.
|
Cardiovasc Ther
|
2013
|
0.78
|
|
73
|
Predicting the effectiveness of prevention: a role for epidemiological modeling.
|
J Prim Prev
|
2008
|
0.77
|
|
74
|
Cardiovascular medication use following percutaneous coronary intervention: the Australian experience.
|
Cardiovasc Ther
|
2014
|
0.77
|
|
75
|
Cardio classics revisited: focus on the role of amlodipine.
|
Integr Blood Press Control
|
2012
|
0.77
|
|
76
|
Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention.
|
Am J Cardiol
|
2011
|
0.77
|
|
77
|
Predictors of annual pharmaceutical costs in Australia for community-based individuals with, or at risk of, cardiovascular disease: analysis of Australian data from the REACH registry.
|
Am J Cardiovasc Drugs
|
2010
|
0.77
|
|
78
|
Forgot to fast?: The importance on plasma glucose values.
|
Diabetes Care
|
2002
|
0.76
|
|
79
|
Statins for people at low risk of cardiovascular disease.
|
Lancet
|
2012
|
0.76
|
|
80
|
Survival in patients with myocardial infarction complicated by out-of-hospital cardiac arrest undergoing emergency percutaneous coronary intervention.
|
Int J Cardiol
|
2011
|
0.76
|
|
81
|
Health-Risk Factors and the Prevalence of Chronic Kidney Disease: Cross-Sectional Findings from a National Cohort of 87,143 Thai Open University Students.
|
Glob J Health Sci
|
2015
|
0.76
|
|
82
|
Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial.
|
BMC Endocr Disord
|
2014
|
0.75
|
|
83
|
Why we need a national registry in interventional cardiology.
|
Med J Aust
|
2009
|
0.75
|
|
84
|
Cost-utility of angiotensin-converting enzyme inhibitor-based treatment compared with thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as comorbidity.
|
Medicine (Baltimore)
|
2015
|
0.75
|
|
85
|
Protocol for a pilot randomised controlled clinical trial to compare the effectiveness of a graduated three layer straight tubular bandaging system when compared to a standard short stretch compression bandaging system in the management of people with venous ulceration: 3VSS2008.
|
Trials
|
2010
|
0.75
|
|
86
|
Cost-effectiveness of optimizing use of statins in Australia: using outpatient data from the REACH Registry.
|
Clin Ther
|
2011
|
0.75
|
|
87
|
Impact of smoking status on early and late outcomes after isolated aortic valve replacement surgery.
|
J Heart Valve Dis
|
2013
|
0.75
|
|
88
|
Predicting the impact of polypill use in a metabolic syndrome population: an effectiveness and cost-effectiveness analysis.
|
Am J Cardiovasc Drugs
|
2013
|
0.75
|
|
89
|
Pet ownership and survival in the elderly hypertensive population.
|
J Hypertens
|
2017
|
0.75
|
|
90
|
Hypertension, antihypertensive treatment and cancer incidence and mortality: a pooled collaborative analysis of 12 Australian and New Zealand cohorts.
|
J Hypertens
|
2016
|
0.75
|
|
91
|
Cardiovascular risk factor control in Australia: current status and implications for the future.
|
Aust Fam Physician
|
2005
|
0.75
|
|
92
|
Does the addition of a radial artery graft improve survival after higher risk coronary artery bypass grafting? A propensity-score analysis of a multicentre database.
|
Eur J Cardiothorac Surg
|
2013
|
0.75
|
|
93
|
Craniofacial fracture patterns in all terrain vehicle injuries.
|
Ann Plast Surg
|
2015
|
0.75
|
|
94
|
Training surgeon status is not associated with an increased risk of early or late mortality after isolated aortic valve replacement surgery.
|
Cardiol J
|
2013
|
0.75
|
|
95
|
Training in mitral valve surgery need not affect early outcomes and midterm survival: a multicentre analysis.
|
Eur J Cardiothorac Surg
|
2011
|
0.75
|
|
96
|
Outcomes and excess costs among patients with cardiovascular disease.
|
Heart Lung Circ
|
2013
|
0.75
|
|
97
|
Use of drug-eluting stents in Victorian public hospitals.
|
Med J Aust
|
2006
|
0.75
|
|
98
|
Long-term Clinical Outcomes of Transient and Persistent No-Reflow Following Percutaneous Coronary Intervention (PCI): A Multi-Center Australian Registry.
|
EuroIntervention
|
2017
|
0.75
|
|
99
|
Efficacy of a Procedure-Specific Education Module on Informed Consent in Plastic Surgery.
|
Ann Plast Surg
|
2017
|
0.75
|
|
100
|
Analysis of a Resident Aesthetic Clinic: Process for Rhinoplasty, Resident Experience, and Patient Satisfaction.
|
Ann Plast Surg
|
2017
|
0.75
|
|
101
|
Cardiovascular readmissions and excess costs following percutaneous coronary intervention in patients with chronic kidney disease: data from a large multi-centre Australian registry.
|
Int J Cardiol
|
2013
|
0.75
|
|
102
|
Does preoperative atrial fibrillation portend a poorer prognosis in patients undergoing isolated aortic valve replacement? A multicentre Australian study.
|
Can J Cardiol
|
2012
|
0.75
|
|
103
|
Excellent short- and long-term outcomes after concomitant aortic valve replacement and coronary artery bypass grafting performed by surgeons in training.
|
J Thorac Cardiovasc Surg
|
2012
|
0.75
|
|
104
|
Treatment of hypertension in the elderly: new findings in older subjects.
|
Ital Heart J
|
2003
|
0.75
|
|
105
|
Predictors of failure to initiate randomized treatment in a large trial of antihypertensive drug therapy in the aged.
|
Am J Hypertens
|
2005
|
0.75
|
|
106
|
Notice of Retraction: Ramipril Markedly Improves Walking Ability in Patients With Peripheral Arterial Disease.
|
Ann Intern Med
|
2015
|
0.75
|
|
107
|
Implementing Assessment Methods in Plastic Surgery.
|
Plast Reconstr Surg
|
2016
|
0.75
|